TransMedics Group, Inc. Common Stock (TMDX)

Price$67.53

Value ScoreC

Growth ScoreB

Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-61.66%

Price vs S&P 500 (4W)-37.78%

VGM Score49.72

Market Capitalization$2.32B

P/E Ratio (Annual)12.21x

All Metrics

P/CF (Annual)12.04x

Book Value / Share (Quarterly)$14.30

P/TBV (Annual)8.82x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)86.42%

Cash Flow / Share (Quarterly)$4.38

Price vs S&P 500 (YTD)-55.69%

Gross Margin (TTM)59.09%

Net Profit Margin (TTM)27.04%

EPS (TTM)$4.23

10-Day Avg Trading Volume1.38M

EPS Excl Extra (TTM)$4.23

Revenue Growth (5Y)88.21%

EPS (Annual)$4.69

ROI (Annual)19.31%

Gross Margin (Annual)59.92%

Net Profit Margin (5Y Avg)-31.16%

Cash / Share (Quarterly)$13.37

P/E Basic Excl Extra (TTM)13.51x

Revenue Growth QoQ (YoY)21.18%

P/E Normalized (Annual)12.21x

ROA (Last FY)17.81%

Revenue Growth TTM (YoY)30.24%

EBITD / Share (TTM)$2.39

ROE (5Y Avg)-9.39%

Operating Margin (TTM)14.85%

Cash Flow / Share (Annual)$3.90

P/B Ratio4.70x

P/B Ratio (Quarterly)6.95x

Net Income / Employee (Annual)$211,900

EV / Revenue (TTM)4.27x

Net Interest Coverage (TTM)78.80x

ROA (TTM)15.85%

EPS Growth QoQ (YoY)-68.59%

EV / EBITDA (TTM)28.66x

EPS Incl Extra (Annual)$4.69

Current Ratio (Annual)7.14x

Quick Ratio (Quarterly)6.01x

3-Month Avg Trading Volume1.15M

52-Week Price Return-47.37%

EV / Free Cash Flow (Annual)20.34x

P/E Incl Extra (TTM)13.51x

Revenue / Employee (TTM)$708,100

Tangible BV / Share (Quarterly)$14.30

P/S Ratio (Annual)3.84x

Asset Turnover (Annual)0.57x

52-Week High$156.00

Operating Margin (5Y Avg)-29.75%

EPS Excl Extra (Annual)$4.69

CapEx CAGR (5Y)164.23%

Tangible BV CAGR (5Y)60.13%

26-Week Price Return-45.73%

Quick Ratio (Annual)6.41x

13-Week Price Return-50.06%

Total Debt / Equity (Annual)1.08x

Current Ratio (Quarterly)6.74x

Enterprise Value$2.72B

Revenue / Share Growth (5Y)70.45%

Asset Turnover (TTM)0.59x

Book Value / Share Growth (5Y)29.30%

Revenue / Employee (Annual)$674,300

Inventory Turnover (Annual)5.09x

Pretax Margin (Annual)17.76%

Cash / Share (Annual)$14.25

3-Month Return Std Dev72.15%

Gross Margin (5Y Avg)64.56%

Net Income / Employee (TTM)$191,500

ROE (Last FY)40.22%

Net Interest Coverage (Annual)20.89x

EPS Basic Excl Extra (Annual)$4.69

P/FCF (TTM)14.21x

Receivables Turnover (TTM)5.46x

EV / Free Cash Flow (TTM)17.96x

Total Debt / Equity (Quarterly)1.73x

EPS Incl Extra (TTM)$4.23

Receivables Turnover (Annual)6.65x

ROI (TTM)17.05%

P/S Ratio (TTM)3.65x

Pretax Margin (5Y Avg)-33.98%

Revenue / Share (Annual)$14.94

Tangible BV / Share (Annual)$13.75

Forward P/E24.88x

Price vs S&P 500 (52W)-75.58%

P/E Ratio (TTM)13.51x

EPS Growth TTM (YoY)225.15%

Year-to-Date Return-44.76%

5-Day Price Return-2.52%

EPS Normalized (Annual)$4.69

ROA (5Y Avg)-5.43%

Net Profit Margin (Annual)31.43%

Month-to-Date Return-33.33%

Cash Flow / Share (TTM)$-0.92

EBITD / Share (Annual)$2.68

Operating Margin (Annual)17.93%

LT Debt / Equity (Annual)1.06x

P/CF (TTM)10.55x

ROI (5Y Avg)-7.48%

P/E Excl Extra (TTM)13.51x

LT Debt / Equity (Quarterly)1.01x

EPS Basic Excl Extra (TTM)$4.23

P/TBV (Quarterly)6.95x

P/B Ratio (Annual)8.79x

Inventory Turnover (TTM)5.58x

Pretax Margin (TTM)14.05%

Book Value / Share (Annual)$13.81

Price vs S&P 500 (13W)-59.81%

Beta1.92x

P/FCF (Annual)17.39x

Revenue / Share (TTM)$17.57

ROE (TTM)41.92%

52-Week Low$60.10

vGradeC

gGradeB

mGradeF

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.30est. 0.63

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.15

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	Price
TMDXTransMedics Group, Inc. Common Stock	C	B	F	$67.53
MDTMedtronic plc	B	D	D	$73.98
MASIMasimo Corporation	D	D	B	$178.59
LIVNLivaNova PLC Ordinary Shares	C	C	B	$73.81
ITGRInteger Holdings Corporation	B	C	C	$90.16
AXGNAxogen, Inc. Common Stock	F	B	B	$38.72
BLFSBioLife Solutions Inc.	F	B	B	$26.63
CNMDCONMED Corporation	A	C	D	$34.65
INMDInMode Ltd. Ordinary Shares	A	D	C	$13.59
CBLLCeriBell, Inc. Common Stock	D	A	C	$17.61
CVCapsoVision, Inc. Common Stock	F	D	B	$6.90

About

TransMedics Group Inc develops the Organ Care System (OCS), a portable organ perfusion and monitoring platform that preserves donor organs in near-physiologic conditions outside the body. The company's technology addresses significant limitations of traditional cold storage preservation, potentially improving organ quality and transplant outcomes. As a commercial-stage medical technology company, TransMedics is expanding its organ preservation system across multiple transplant disease states.